FDA Inspection
Pine Lake Investments, Inc.Pine Lake Investments, Inc. – FDA Inspection, Mar 8, 2016
Record Details
This FDA Inspection record concerns Pine Lake Investments, Inc., with an inspection on March 8, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Pine Lake Investments, Inc.
- Inspection Date
- March 8, 2016
- Product Type
- Drugs
View Company Profile
ID · 646e61a0-bfdd-43ee-897e-4da39012d284
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 962511
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.182Written records kept in individual logs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pine Lake Investments, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 1, 2026 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 18, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 18, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pine Lake Investments, Inc.
- FDA Inspection 1327394 - 2026-07-01
- FDA Inspection 1140455 - 2021-03-18
- FDA Inspection 723164 - 2011-04-28
- FDA Inspection 571925 - 2009-03-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.